Literature DB >> 32466819

Consular Crisis Management Operations: Special Considerations and Challenges.

Karin Hugelius1.   

Abstract

Assisting the increasing number of tourists and foreign nationals exposed to crises situations in third countries-many of them far from home and extremely vulnerable-presents significant challenges. Despite the need to explore consular crisis management from an operational perspective, there are few studies that address the issue. This paper aims to describe the characteristics and context of consular crisis management operations based on personal experiences, scientific papers, grey literature, and key informant interviews.Consular crisis management operations are conducted in a context where the stakeholders and the legal environment may differ from humanitarian or civil protection operations. The physical distance causes logistical challenges and demands specific considerations for both civilian and medical evacuation. Consular crisis management operations often include medical care, psychosocial support activities, and disaster victim identification (DVI) activities. Political and media interest may also add significant challenges to such operations. Therefore, specific knowledge, skills, and preparations are needed for both diplomatic crisis management professionals and health professionals. Further research on consular crisis management activities-as well as the concept of consular crisis management itself-is strongly needed.

Keywords:  consular crisis management; crisis management; disasters; medical evacuation; tourists

Mesh:

Year:  2020        PMID: 32466819     DOI: 10.1017/S1049023X20000655

Source DB:  PubMed          Journal:  Prehosp Disaster Med        ISSN: 1049-023X            Impact factor:   2.040


  1 in total

1.  How have governments supported citizens stranded abroad due to COVID-19 travel restrictions? A comparative analysis of the financial and health support in eleven countries.

Authors:  Pippa McDermid; Adam Craig; Meru Sheel; Holly Seale
Journal:  BMC Infect Dis       Date:  2022-02-20       Impact factor: 3.090

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.